Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Severe Acute Pancreatitis with Infectious Complications
NCT02318147Phase 1Unknown
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Nov 2016
- Primary completion
- Dec 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label trial of fecal microbiome transplant in acute pancreatitis (AP) (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: The control of infectious complications. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02318147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318147.